Oct 22, 2025 · Herceptin (chemical name: trastuzumab) is a HER2 inhibitor targeted therapy. Herceptin works against HER2-positive breast cancers by blocking the ability of the cancer …

Trastuzumab (brand name: Herceptin) is a targeted therapy known as a monoclonal antibody, a modified version of an immune system protein, that can attach to proteins on HER2-positive …

Aug 10, 2021 · Targeted Drug Therapy for Breast Cancer Targeted drug therapy uses medicines that are directed at (target) proteins on breast cancer cells that help them grow, spread, and …

Dec 2, 2025 · Targeted therapy is a treatment for certain types of breast cancer. Learn about types of targeted therapy, common side effects, and more.

Trastuzumab (Herceptin) is a targeted therapy for treating breast cancer. Find out when it's used, how it works and possible side effects.

Apr 14, 2024 · Find out all you need to know about Herceptin (trastuzumab) for early and more advanced HER2-positive breast cancer, including what to expect, outcomes, side effects, and …

Mar 3, 2025 · Learn about the drug trastuzumab (Herceptin), which is used to treat metastatic breast cancer and early breast cancer (including lymph node-positive and some lymph node …

Apr 17, 2025 · Learn how targeted therapies, including monoclonal antibodies (such as Herceptin or Trastuzumab), can be used to treat breast cancer.

Learn about the mechanism of action for Herceptin® (trastuzumab) and how it's designed to work treating HER2+ Metastatic Breast Cancer. See Full Safety and Boxed Warnings for more …

Nov 7, 2024 · Herceptin, a HER2 inhibitor targeted therapy, treats breast cancer. Learn if it's right for you and more here.